Bobak Azamian, MD, PhD
FounderFounder at Tarsus Pharmaceuticals
Irvine, California, United States
FoundedTarsus Pharmaceuticals
About
Bobak Azamian, MD, PhD, is Co-founder, Chairman, and CEO of Tarsus Pharmaceuticals, Inc., which he founded in 2016. Under his leadership, the company completed an IPO, raised approximately $800 million in financing, and in 2023 launched XDEMVY, an FDA-approved treatment for Demodex blepharitis. Tarsus is developing additional therapies for conditions including ocular rosacea and Lyme disease prevention.
Founder at Tarsus Pharmaceuticals
Intro paths
→
In turn, Bobak can intro founders to Tarsus Pharmaceuticals's investors below.
Experience
- Tarsus Pharmaceuticals, Inc.Chairmancurrent2022 — present
- Tarsus Pharmaceuticals, Inc.President and CEOcurrent2018 — present
- Vibrato Medical, Inc.Board Membercurrent2022 — present
- Vibrato Medical, Inc.Co-Chair2019 — 2022
- UCI Edwards Lifesciences Foundation, Cardiovascular Innovation and Research Center (CIRC)Leadership Council Membercurrent2012 — present
- Osanni BioChair of the Board2023 — 2026
- Octane OCBoard Member2012 — 2021
- Metavention, Inc.President and CMO2013 — 2018
- Versant VenturesInvestment Professional2011 — 2013
- Third Rock VenturesSenior Associate2009 — 2011
- Third Rock VenturesConsultant2007 — 2009
- Brigham and Women's HospitalAttending Hospitalist2009 — 2011
- Brigham and Women's HospitalResidency, Internal Medicine2006 — 2009
- AmgenConsultant2003
Skills & more
Biotechnology99Medical Devices99Healthcare39Molecular Biology5Start-ups25Corporate Development8Due Diligence6Research5R&D12Clinical Trials8Commercialization17Entrepreneurship11
+11 more
Healthcare Information TechnologyDrug DiscoveryDrug DevelopmentClinical ResearchInternal MedicineLife SciencesClinical DevelopmentBiopharmaceuticalsMicrosoft OfficeStrategic PlanningLeadershipFrom Bobak's professional profile.
Frequently asked questions
- Who is Bobak Azamian, MD, PhD?
- Bobak Azamian, MD, PhD, is Co-founder, Chairman, and CEO of Tarsus Pharmaceuticals, Inc., which he founded in 2016. Under his leadership, the company completed an IPO, raised approximately $800 million in financing, and in 2023 launched XDEMVY, an FDA-approved treatment for Demodex blepharitis. Tarsus is developing additional therapies for conditions including ocular rosacea and Lyme disease prevention.
- Where does Bobak Azamian, MD, PhD work?
- Bobak Azamian, MD, PhD is Founder of Tarsus Pharmaceuticals.
- What companies did Bobak Azamian, MD, PhD found?
- Bobak Azamian, MD, PhD founded Tarsus Pharmaceuticals.
- Where did Bobak Azamian, MD, PhD go to school?
- Bobak Azamian, MD, PhD studied at Harvard Medical School (Doctor of Medicine (MD)); University of Oxford (Doctor of Philosophy (PhD), Chemistry); Rice University (BA, Physics (Biophysics)).
Same school
Also attended Harvard Medical School143
Niko BonatsosVerdict Capital founder and pre-consensus investor formerly at General CatalystAnthony PhilippakisInvestor at GV (Google Ventures)Ben RobbinsInvestor at GV (Google Ventures)David ReshefInvestor at GV (Google Ventures)Krishna YeshwantInvestor at GV (Google Ventures)Morgan CheathamPartner and Head of Healthcare and Life Sciences at Breyer Capital
.png)
+ 137 more
Also attended University of Oxford982
Reid HoffmanCo-founder of LinkedIn; Partner at GreylockMichael MoritzFormer Partner at Sequoia Capital; Senior Adviser at Sequoia HeritageBrad GerstnerFounder & CEO of Altimeter CapitalGabriel PereyraCo-founder & President of HarveyDominic JacquessonInvestor at Index VenturesErin Price-WrightInvestor at Index Ventures
+ 976 more
Also attended Rice University137
Brian ArmstrongCo-founder & CEO of CoinbaseAbigail JohnsonPartner, Chief Operating Officer at Sapphire VenturesEdi DanalacheSenior Associate at Scale Venture PartnersJim BridenstineManaging Partner, Artemis Group at Cortado VenturesPatrick OkoraforDirector of Finance at Mercury FundSharon KedarCo-Founder, Partner at Northpond Ventures
+ 131 more
.avif)
